Newlink
- All
- News
-
Guinea to Start Final Trials of Ebola Vaccines This Week
Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.
-
Ebola Vaccine Trial Suspended After Side Effects
Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects.
-
Canadian Ebola Vaccine to be Tested in Europe, Gabon, Kenya
Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.
-
NewLink Genetics Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
NewLink Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
Guinea to Start Final Trials of Ebola Vaccines This Week
Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.
-
Ebola Vaccine Trial Suspended After Side Effects
Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects.
-
Canadian Ebola Vaccine to be Tested in Europe, Gabon, Kenya
Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.
-
NewLink Genetics Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
-
NewLink Says Ebola Vaccine Trial Could Start in Weeks
NewLink Genetics Corp, which licensed an Ebola vaccine developed by Canadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday.
